KeyBanc: 'Teradyne (TER) Testing Investor Patience; Frustrating Stock to Own'; PT Lowered
Tweet Send to a Friend
KeyBanc analyst Steve Barger lowered the price target on Teradyne (NASDAQ: TER) to $140.00 (from $150.00) while maintaining a Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
